A series of proposed megamergers in the global agrochemicals and seed industries — capped by Bayer's record $ 66 billion cash bid for Monsanto — raise fears of a pricing monopoly in the farm - supply industry and threat to the global food supply. (gfmag.com)
Since AstraZeneca ($ AZN) successfully managed to evade an unwanted megamerger with Pfizer last year, harshly criticizing Pfizer's R&D track record in the process, the pharma giant has been busy doing a range of ambitious deals. (fiercebiotech.com)
This insurance megamerger was also blocked by a federal judge on antitrust grounds, but what followed was a protracted legal dispute between Anthem and Cigna over ending the deal. (fiercehealthcare.com)